MENU
+Compare
EKSO
Stock ticker: NASDAQ
AS OF
Jun 5 closing price
Price
$4.31
Change
-$0.05 (-1.15%)
Capitalization
24.35M

EKSO Ekso Bionics Holdings Inc Forecast, Technical & Fundamental Analysis

Ekso Bionics Holdings Inc designs, develops and sells exoskeleton technology used in healthcare and industrial markets... Show more

EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for EKSO with price predictions
Jun 05, 2025

EKSO's RSI Oscillator ascends from oversold territory

The RSI Indicator for EKSO moved out of oversold territory on May 27, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 44 similar instances when the indicator left oversold territory. In of the 44 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 61 cases where EKSO's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on June 04, 2025. You may want to consider a long position or call options on EKSO as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EKSO advanced for three days, in of 262 cases, the price rose further within the following month. The odds of a continued upward trend are .

EKSO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 115 cases where EKSO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EKSO turned negative on May 08, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

EKSO moved below its 50-day moving average on May 15, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for EKSO crossed bearishly below the 50-day moving average on May 19, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where EKSO declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.875) is normal, around the industry mean (24.191). P/E Ratio (0.000) is within average values for comparable stocks, (79.080). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (1.001) is also within normal values, averaging (42.393).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. EKSO’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EKSO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
EKSO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

EKSO is expected to report earnings to fall 33.33% to -7 cents per share on July 24

Ekso Bionics Holdings Inc EKSO Stock Earnings Reports
Q2'25
Est.
$-0.08
Q1'25
Missed
by $0.04
Q4'24
Missed
by $0.05
Q3'24
Beat
by $0.01
Q2'24
Est.
$-0.13
The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -7 cents. With 50.10K shares outstanding, the current market capitalization sits at 24.35M.
A.I. Advisor
published General Information

General Information

a robotic exoskeleton company, which designs and develops exoskeletons and wearable robots

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
101 Glacier Point
Phone
+1 510 984-1761
Employees
73
Web
https://www.eksobionics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GDHG1.530.17
+12.50%
Golden Heaven Group Holdings Ltd.
WST218.587.15
+3.38%
West Pharmaceutical Services
MRC12.600.03
+0.24%
MRC Global
BCO83.380.06
+0.07%
Brink's Company (The)
SFST34.64-0.60
-1.70%
Southern First Bancshares

EKSO and Stocks

Correlation & Price change

A.I.dvisor tells us that EKSO and PAVM have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EKSO and PAVM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EKSO
1D Price
Change %
EKSO100%
-1.38%
PAVM - EKSO
28%
Poorly correlated
+4.03%
RVP - EKSO
26%
Poorly correlated
-1.93%
LFWD - EKSO
26%
Poorly correlated
-3.25%
MBOT - EKSO
26%
Poorly correlated
-2.90%
TMDX - EKSO
26%
Poorly correlated
+4.45%
More